3 completed, 2 terminated. 3 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow VRS-317: new trials by email Literature Review of VRS-317 trials Research Report on VRS-317
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD) somavaratan - Adult Growth Hormone Deficiency (AGHD) | Phase 2 | Terminated | Versartis Inc. | 36 | 2016-02-11 | 2023-04-13 |
| Long-Acting Growth Hormone in Children Compared to Daily rhGH Somavaratan, rhGH - Growth Disorders | Phase 3 | Completed | Versartis Inc. | 138 | 2015-08-26 | 2022-12-30 |
| Versartis International Trial in Adults With Long-Acting Growth Hormone somavaratan - Adult Growth Hormone Deficiency | Phase 2 | Completed | Versartis Inc. | 36 | 2015-07-01 | 2022-07-26 |
| Versartis Long-Term Safety Study of Somavaratan somavaratan - Pediatric Growth Hormone Deficiency | Phase 2 / Phase 3 | Terminated | Versartis Inc. | 385 | 2014-03-03 | 2018-03-09 |
| VRS-317 in Adult Subjects With Growth Hormone Deficiency VRS-317 - Growth Hormone Deficiency | Phase 1 | Completed | Versartis Inc. | 50 | 2011-03-01 | 2012-07-23 |
Dwarfism, Pituitary (5) · Growth Disorders (2) · Bone Diseases (1) · Bone Diseases, Developmental (1) · Bone Diseases, Endocrine (1) · Brain Diseases (1) · Dwarfism (1) · Failure to Thrive (1) · Hypopituitarism (1) · Musculoskeletal Diseases (1) · Pituitary Diseases (1)
Versartis Inc. (5)
United States (2) · Australia (1) · Germany (1) · United Kingdom (1)
Will Charlton, MD (3) · Daniela Rogoff, MD, PhD (1) · Mark Kipnes, MD (1)